Lamivudine
- Product NDC
- 60687-720
- Requested package NDC
- 60687-720-21
- 11-digit product format
- 606870720
- Labeler code
- 60687
- Product ID
- 60687-720_223f034f-e646-cd65-e063-6394a90a3505
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lamivudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA091606
- Marketing category
- ANDA
- Marketing start
- 2023-01-19
- Substance
- LAMIVUDINE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091606-001 | LAMIVUDINE | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | |
| A091606-002 | LAMIVUDINE | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A091606-001 | AB |
| A091606-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A091606-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2011-12-02 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A091606-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2011-12-02 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A091606-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A091606-002 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A091606-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A091606-002 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A091606-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A091606-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091606-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091606-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A091606-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A091606-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091606-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091606-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091606-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091606-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091606-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091606-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091606-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091606-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091606-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091606-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091606-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091606-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A091606-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A091606-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091606-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091606-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091606-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091606-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091606-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091606-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A091606-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A091606-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A091606-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A091606-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A091606-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A091606-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A091606-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A091606-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A091606-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A091606-002 | AB | 1 | 74a2ff9319b5… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lamivudine
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LAMIVUDINE | 150 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2T8Q726O95 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 199147 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7ad3a998-8e4d-43a0-8930-8f7a6ae539b4 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| aaa99659-c62c-7281-d402-9590409850c2 | Product name | 6 | 20260128 |
| a02e6d35-8cc4-a80a-fd4d-d3ec16f69b8e | Product name | 8 | 20250626 |
| 4ef90d80-1289-4267-a2bb-01c741d1208f | Product name | 1 | 20230829 |
| 72dcca4e-6eae-4149-a92b-264c2a07004f | Product name | 1 | 20230808 |
| 3832141c-c294-474a-9473-1052c891450e | Product name | 2 | 20230105 |
| 320f244d-8b4e-4893-9f14-104b2a8e0aaf | Product name | 2 | 20201007 |
| 7ff71f22-5b66-4a3d-bf64-671893a6409d | Product name | 2 | 20201007 |
| 3644e9cf-6f4d-4b63-b875-6a4b5187c47e | Product name | 1 | 20190703 |
| 0e579b5c-f0b5-e690-466e-4a5e809e2c68 | Product name | 3 | 20190627 |
| 6f122144-2ceb-48fa-a906-0d2eb742717e | Product name | 1 | 20190624 |
| 8051c8a3-aee0-45a2-a236-8ee3f9e65f67 | Product name | 1 | 20181211 |
| fbdbfbef-2c33-0298-4fef-f6693e670fe1 | Product name | 7 | 20181210 |
| d07e0b9e-e041-41dc-942a-a2a6601dc221 | Product name | 1 | 20181029 |
| af19b329-4f44-cd81-491a-fbb7fe7a079f | Product name | 2 | 20151013 |
| c873f14e-2add-4d53-b9b3-bf775efd3702 | Product name | 1 | 20150325 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60687-720-11 | Lamivudine | 1 in 1 BLISTER PACK | TABLET, FILM COATED | 1 | 2 | |
| 60687-720-21 | Lamivudine | 30 in 1 CARTON | TABLET, FILM COATED | 30 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60687-720-11 | EA - Each | 60687-720 | fb113567-10b8-40d2-8ccb-a26f2a22bfb5 | 1 | 2023-02-06 |
| 60687-720-21 | EA - Each | 60687-720 | 48cfb5a7-de98-48f3-a47b-5ce94a17e9f2 | 1 | 2023-02-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LAMIVUDINE | LAMIVUDINE | Major Pharmaceuticals | 6fd4d6b9-65ea-4988-8d6f-dd220ec5052d | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 091606 ANDA091606 |
| LAMIVUDINE | LAMIVUDINE | Golden State Medical Supply, Inc. | f3637209-303e-4232-ae79-07315a990973 | 2025-11-24 | Boxed warning, Warnings, Adverse reactions | 091606 ANDA091606 |
| LAMIVUDINE | LAMIVUDINE | Apotex Corp. | 34c02bcc-d6ff-99d4-8e6a-4a91908adca8 | 2025-09-19 | Boxed warning, Warnings, Adverse reactions | 091606 ANDA091606 |
| Lamivudine | LAMIVUDINE | American Health Packaging | 7ad3a998-8e4d-43a0-8930-8f7a6ae539b4 | 2024-09-16 | Boxed warning, Warnings, Adverse reactions | 091606 ANDA091606 60687-720-21 60687-720 60687072021 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 199147 | lamiVUDine 150 MG Oral Tablet | PSN | 7ad3a998-8e4d-43a0-8930-8f7a6ae539b4 | 2 |
| 199147 | lamivudine 150 MG Oral Tablet | SCD | 7ad3a998-8e4d-43a0-8930-8f7a6ae539b4 | 2 |
| 199147 | 3TC 150 MG Oral Tablet | SY | 7ad3a998-8e4d-43a0-8930-8f7a6ae539b4 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 60687-720-21 | 60687072021 | 30 BLISTER PACK in 1 CARTON (60687-720-21) / 1 TABLET, FILM COATED in 1 BLISTER PACK (60687-720-11) | 30 blister pack | 2023-01-19 | 0000-00-00 | No | No | Current |